IOVA · Iovance Biotherapeutics, Inc.

$6.98 +0.46 (+7.06%) At close · Aug 14

Market Cap

$3.16B

452.97M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
8-K	2026-08-06	—
8-K	2026-08-06	—
10-Q	2026-08-06	2026-06-30
8-K	2026-07-02	2026-06-30
8-K	2026-06-10	2026-06-04
Investor Event Transcript	2026-06-04	2026-06-30
10-Q	2026-05-07	2026-03-31
8-K	2026-05-07	—
DEF 14A	2026-04-28	2026-06-10
Investor Event Transcript	2026-03-31	—
8-K	2026-03-20	2026-03-17
8-K	2026-02-24	—
10-K	2026-02-24	2025-12-31
8-K	2026-01-09	—
8-K	2025-11-06	—
10-Q	2025-11-06	2025-09-30
8-K	2025-08-29	—
8-K	2025-08-22	—
8-K	2025-08-19	2025-08-18
10-Q	2025-08-07	2025-06-30
8-K	2025-08-07	—
8-K	2025-07-15	—
8-K	2025-07-03	2025-06-30
8-K	2025-06-13	2025-06-10
8-K	2025-06-10	—
10-Q	2025-05-08	2025-03-31
8-K	2025-05-08	—
DEF 14A	2025-04-28	2025-06-10
10-K	2025-02-27	2024-12-31
8-K	2025-02-27	—
8-K	2025-02-10	—
8-K	2024-11-21	2024-11-15
8-K	2024-11-08	2024-11-07
10-Q	2024-11-07	2024-09-30
8-K	2024-11-07	—
8-K	2024-08-09	2024-08-08
10-Q	2024-08-08	2024-06-30
8-K	2024-08-08	—
8-K	2024-06-28	—
8-K	2024-06-11	—
8-K	2024-06-03	2024-05-31
8-K	2024-05-24	2024-05-23
8-K	2024-05-09	—
10-Q	2024-05-09	2024-03-31
DEF 14A	2024-04-29	2024-06-11
8-K	2024-04-03	—
8-K	2024-03-29	2024-03-26
8-K	2024-03-04	—
8-K	2024-02-29	2024-02-28
8-K	2024-02-28	—

Showing 1–50 of 144 filings

Key facts CIK 1425205 CUSIP 462260100 13F (30d) 277 filings 274 filers Visit website Investor relations